Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-25-048624

Director sold 22,000 shares at $5.64 ($124,047)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SATO VICKI L Director 2025-11-03 Sale 10b5-1 −22,000 $5.64 $124,047 1,210,391 D
Open-market sales · 22,000 sh · avg $5.64 · $124,047
Loading xslF345X05/wk-form4_1762275483.xml…